{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:24:52Z","timestamp":1792445092784,"version":"4.5.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular complications contribute to adverse outcomes in patients with influenza and severe acute respiratory syndrome coronavirus 2 infections. While the association of respiratory syncytial virus (RSV) infection with cardiovascular events (CVEs) has been described, data are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective study of hospitalized patients with RSV in Rochester, New York, during the 2017\u20132020 winter seasons. A range of CVEs requiring medical intervention such as new congestive heart failure (CHF), atrial fibrillation or flutter (AF), myocardial infarction (MI), supraventricular and ventricular arrhythmias, venous thromboembolism and stroke, and exacerbations of preexisting CHF and AF were included. The cumulative numbers of CVE during a prehospitalization 6-month period, high-risk period of 28 days from admission, and late-risk period from day 29 to 6 months after admission were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 471 patients evaluated, 37% experienced CVEs in the high-risk period, with CHF (25%), AF (13%), and MI (9%) being the most common. Of these, 44% occurred in patients with no personal history of these conditions. However, age \u226565 years, preexisting hypertension, CHF, AF, and coronary artery disease, as well as the presence of \u22653 classic cardiac risk factors, were significantly associated with CVE during the high-risk period. Cardiac complications were associated with increased mortality in the high-risk period. The incidence rate ratio of CVEs was 18.5 and 1.6 during the high-risk and late-risk periods, respectively, compared to the prehospitalization period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hospitalization with RSV was associated with increased risk of new CVEs as well as exacerbations of preexisting cardiovascular conditions, particularly in patients with comorbidities. This information is relevant for informed decision-making on RSV vaccination.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaf310","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T07:49:53Z","timestamp":1749628193000},"page":"e396-e403","source":"Crossref","is-referenced-by-count":17,"title":["Comprehensive Analysis of Cardiovascular Events and Risk Factors in Patients Hospitalized With Respiratory Syncytial Virus"],"prefix":"10.1093","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6339-7428","authenticated-orcid":false,"given":"Paulina","family":"Sudnik","sequence":"first","affiliation":[{"name":"Infectious Disease Division, Department of Medicine, University of Rochester Medical Center , Rochester, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8792-8877","authenticated-orcid":false,"given":"Edward E","family":"Walsh","sequence":"additional","affiliation":[{"name":"Infectious Disease Division, Department of Medicine, University of Rochester Medical Center , Rochester, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7742-5352","authenticated-orcid":false,"given":"Angela R","family":"Branche","sequence":"additional","affiliation":[{"name":"Infectious Disease Division, Department of Medicine, University of Rochester Medical Center , Rochester, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8384-6180","authenticated-orcid":false,"given":"Md Rayhanul","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Public Health Science, University of Rochester School of Medicine , Rochester, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7141-9701","authenticated-orcid":false,"given":"Ann R","family":"Falsey","sequence":"additional","affiliation":[{"name":"Infectious Disease Division, Department of Medicine, University of Rochester Medical Center , Rochester, New York ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"2026031306473965300_ciaf310-B1","first-page":"2159","article-title":"Public health weekly reports for November 11, 1932","volume":"47","year":"1932","journal-title":"Public Health Rep (1896)"},{"key":"2026031306473965300_ciaf310-B2","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa041747","article-title":"Risk of myocardial infarction and stroke after acute infection or vaccination","volume":"351","author":"Smeeth","year":"2004","journal-title":"N Engl J Med"},{"key":"2026031306473965300_ciaf310-B3","doi-asserted-by":"crossref","first-page":"1900199","DOI":"10.2807\/1560-7917.ES.2020.25.17.1900199","article-title":"Acute myocardial infarctions and stroke triggered by laboratory-confirmed respiratory infections in Denmark, 2010 to 2016","volume":"25","author":"Ohland","year":"2020","journal-title":"Euro Surveill"},{"key":"2026031306473965300_ciaf310-B4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/cid\/cix1144","article-title":"Laboratory-confirmed respiratory infections as predictors of hospital admission for myocardial infarction and stroke: time-series analysis of English data for 2004\u20132015","volume":"67","author":"Blackburn","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026031306473965300_ciaf310-B5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/biomedicines11010071","article-title":"Cardiovascular complications of viral respiratory infections and COVID-19","volume":"11","author":"Franczuk","year":"2022","journal-title":"Biomedicines"},{"key":"2026031306473965300_ciaf310-B6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(21)00896-5","article-title":"Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study","volume":"398","author":"Katsoularis","year":"2021","journal-title":"Lancet"},{"key":"2026031306473965300_ciaf310-B7","doi-asserted-by":"crossref","first-page":"1701794","DOI":"10.1183\/13993003.01794-2017","article-title":"Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland","volume":"51","author":"Warren-Gash","year":"2018","journal-title":"Eur Respir J"},{"key":"2026031306473965300_ciaf310-B8","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"key":"2026031306473965300_ciaf310-B9","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1093\/infdis\/jiae070","article-title":"Risk of cardiovascular events after influenza: a population-based self-controlled case series study, Spain, 2011\u20132018","volume":"230","author":"Mu\u00f1oz-Quiles","year":"2024","journal-title":"J Infect Dis"},{"key":"2026031306473965300_ciaf310-B10","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S1473-3099(22)00223-7","article-title":"Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study","volume":"22","author":"Burn","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2026031306473965300_ciaf310-B11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/ije\/dyr012","article-title":"Recent respiratory infection and risk of venous thromboembolism: case-control study through a general practice database","volume":"40","author":"Clayton","year":"2011","journal-title":"Int J Epidemiol"},{"key":"2026031306473965300_ciaf310-B12","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41598-021-81166-y","article-title":"Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities","volume":"11","author":"Tan","year":"2021","journal-title":"Sci Rep"},{"key":"2026031306473965300_ciaf310-B13","doi-asserted-by":"crossref","first-page":"109213","DOI":"10.1016\/j.thromres.2024.109213","article-title":"Risks of major arterial and venous thrombotic diseases after hospitalisation for influenza, pneumonia, and COVID-19: a population-wide cohort in 2.6 million people in Wales","volume":"245","author":"Keene","year":"2025","journal-title":"Thromb Res"},{"key":"2026031306473965300_ciaf310-B14","doi-asserted-by":"crossref","first-page":"570681","DOI":"10.3389\/fimmu.2020.570681","article-title":"Immune mechanisms in cardiovascular diseases associated with viral infection","volume":"11","author":"Gopal","year":"2020","journal-title":"Front Immunol"},{"key":"2026031306473965300_ciaf310-B15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/jis309","article-title":"Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults","volume":"206","author":"Widmer","year":"2012","journal-title":"J Infect Dis"},{"key":"2026031306473965300_ciaf310-B16","doi-asserted-by":"crossref","first-page":"105635","DOI":"10.1016\/j.jcv.2023.105635","article-title":"Respiratory syncytial virus-related hospital stays in adults in France from 2012 to 2021: a national hospital database study","volume":"171","author":"Loubet","year":"2024","journal-title":"J Clin Virol"},{"key":"2026031306473965300_ciaf310-B17","doi-asserted-by":"crossref","first-page":"S577","DOI":"10.1093\/infdis\/jiz059","article-title":"Global disease burden estimates of respiratory syncytial virus\u2013associated acute respiratory infection in older adults in 2015: a systematic review and meta-analysis","volume":"222","author":"Shi","year":"2020","journal-title":"J Infect Dis"},{"key":"2026031306473965300_ciaf310-B18","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1093\/cid\/ciad031","article-title":"Prevalence and clinical outcomes of respiratory syncytial virus vs influenza in adults hospitalized with acute respiratory illness from a prospective multicenter study","volume":"76","author":"Begley","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026031306473965300_ciaf310-B19","doi-asserted-by":"crossref","first-page":"e0182321","DOI":"10.1371\/journal.pone.0182321","article-title":"The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: a systematic review","volume":"12","author":"Colosia","year":"2017","journal-title":"PLoS One"},{"key":"2026031306473965300_ciaf310-B20","doi-asserted-by":"crossref","first-page":"e244954","DOI":"10.1001\/jamanetworkopen.2024.4954","article-title":"Severity of respiratory syncytial virus vs COVID-19 and influenza among hospitalized US adults","volume":"7","author":"Surie","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026031306473965300_ciaf310-B21","doi-asserted-by":"crossref","first-page":"e2444756","DOI":"10.1001\/jamanetworkopen.2024.44756","article-title":"Burden of respiratory syncytial virus\u2013associated hospitalizations in US adults, October 2016 to September 2023","volume":"7","author":"Havers","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026031306473965300_ciaf310-B22","doi-asserted-by":"crossref","first-page":"ofad702","DOI":"10.1093\/ofid\/ofad702","article-title":"Clinical outcomes of US adults hospitalized for COVID-19 and influenza in the Respiratory Virus Hospitalization Surveillance Network, October 2021\u2013September 2022","volume":"11","author":"Kojima","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2026031306473965300_ciaf310-B23","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2018.02.013","article-title":"Respiratory syncytial virus and associations with cardiovascular disease in adults","volume":"71","author":"Ivey","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026031306473965300_ciaf310-B24","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"},{"key":"2026031306473965300_ciaf310-B25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.15585\/mmwr.mm7240a1","article-title":"Characteristics and outcomes among adults aged \u226560 years hospitalized with laboratory-confirmed respiratory syncytial virus\u2014RSV-NET, 12 states, July 2022\u2013June 2023","volume":"72","author":"Havers","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026031306473965300_ciaf310-B26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/irv.12754","article-title":"Severity and mortality of respiratory syncytial virus vs influenza A infection in hospitalized adults in China","volume":"14","author":"Zhang","year":"2020","journal-title":"Influenza Other Respir Viruses"},{"key":"2026031306473965300_ciaf310-B27","doi-asserted-by":"crossref","first-page":"e0214517","DOI":"10.1371\/journal.pone.0214517","article-title":"Characteristics of hospitalized adult patients with laboratory documented influenza A, B and respiratory syncytial virus\u2014a single center retrospective observational study","volume":"14","author":"Cohen","year":"2019","journal-title":"PLoS One"},{"key":"2026031306473965300_ciaf310-B28","doi-asserted-by":"crossref","first-page":"574128","DOI":"10.3389\/fmed.2020.574128","article-title":"The clinical characteristics and outcomes of adult patients with pneumonia related to three paramyxoviruses","volume":"7","author":"Chen","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2026031306473965300_ciaf310-B29","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jamainternmed.2024.0212","article-title":"Acute cardiac events in hospitalized older adults with respiratory syncytial virus infection","volume":"184","author":"Woodruff","year":"2024","journal-title":"JAMA Intern Med"},{"key":"2026031306473965300_ciaf310-B30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jcv.2019.07.001","article-title":"Clinical manifestations and outcomes of respiratory syncytial virus infection in adult hospitalized patients","volume":"117","author":"Chuaychoo","year":"2019","journal-title":"J Clin Virol"},{"key":"2026031306473965300_ciaf310-B31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/s12879-014-0665-2","article-title":"Respiratory syncytial virus infection\u2013associated hospitalization in adults: a retrospective cohort study","volume":"14","author":"Volling","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2026031306473965300_ciaf310-B32","doi-asserted-by":"crossref","first-page":"e773","DOI":"10.1016\/S2589-7500(21)00203-X","article-title":"Risk of acute respiratory infection and acute cardiovascular events following acute respiratory infection among adults with increased cardiovascular risk in England between 2008 and 2018: a retrospective, population-based cohort study","volume":"3","author":"Davidson","year":"2021","journal-title":"Lancet Digit Health"},{"key":"2026031306473965300_ciaf310-B33","doi-asserted-by":"crossref","first-page":"oeac051","DOI":"10.1093\/ehjopen\/oeac051","article-title":"Prevalence and prognostic implications of myocardial injury in patients with influenza","volume":"2","author":"Nordenskjold","year":"2022","journal-title":"Eur Heart J Open"},{"key":"2026031306473965300_ciaf310-B34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3390\/jpm12040520","article-title":"High-sensitivity troponin T: a potential safety predictive biomarker for discharge from the emergency department of patients with confirmed influenza","volume":"12","author":"Taz\u00f3n-Varela","year":"2022","journal-title":"J Pers Med"},{"key":"2026031306473965300_ciaf310-B35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bj.2020.06.001","article-title":"Cardiac troponin elevation in patients with influenza virus infections","volume":"44","author":"Lippi","year":"2021","journal-title":"Biomed J"},{"key":"2026031306473965300_ciaf310-B36","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2022.08.016","article-title":"Association among myocardial injury and mortality in influenza: a prospective cohort study","volume":"369","author":"Biasco","year":"2022","journal-title":"Int J Cardiol"},{"key":"2026031306473965300_ciaf310-B37","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/ciab595","article-title":"Incidence of respiratory syncytial virus infection among hospitalized adults, 2017\u20132020","volume":"74","author":"Branche","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026031306473965300_ciaf310-B38","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s12325-020-01230-3","article-title":"A real-world analysis of patient characteristics and predictors of hospitalization among US Medicare beneficiaries with respiratory syncytial virus infection","volume":"37","author":"Wyffels","year":"2020","journal-title":"Adv Ther"},{"key":"2026031306473965300_ciaf310-B39","first-page":"145","article-title":"Frequency of troponin elevations in patients with influenza infection during the 2017\u20132018 influenza season","volume":"22","author":"Harris","year":"2019","journal-title":"Int J Cardiol Heart Vasc"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaf310\/63477033\/ciaf310.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/2\/e396\/63477033\/ciaf310.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/82\/2\/e396\/63477033\/ciaf310.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T10:47:49Z","timestamp":1773398869000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/82\/2\/e396\/8160860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6,12]]},"published-print":{"date-parts":[[2026,2,25]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaf310","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,15]]},"published":{"date-parts":[[2025,6,12]]}}}